Original language | English (US) |
---|---|
Pages (from-to) | e87-e91 |
Journal | Haematologica |
Volume | 103 |
Issue number | 2 |
DOIs |
|
State | Published - Jan 31 2018 |
ASJC Scopus subject areas
- Hematology
Access to Document
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia. / Zabriskie, Matthew S.; Antelope, Orlando; Verma, Anupam R.; Draper, Lauren R.; Eide, Christopher A.; Pomicter, Anthony D.; Tran, Thai Hoa; Druker, Brian J.; Tyner, Jeffrey W.; Miles, Rodney R.; Graham, James M.; Hwang, Jae Yeon; Varley, Katherine E.; Toydemir, Reha M.; Deininger, Michael W.; Raetz, Elizabeth A.; O’Hare, Thomas.
In: Haematologica, Vol. 103, No. 2, 31.01.2018, p. e87-e91.Research output: Contribution to journal › Comment/debate › peer-review
}
TY - JOUR
T1 - A novel AGGF1-PDGFRβ fusion in pediatric T-cell acute lymphoblastic leukemia
AU - Zabriskie, Matthew S.
AU - Antelope, Orlando
AU - Verma, Anupam R.
AU - Draper, Lauren R.
AU - Eide, Christopher A.
AU - Pomicter, Anthony D.
AU - Tran, Thai Hoa
AU - Druker, Brian J.
AU - Tyner, Jeffrey W.
AU - Miles, Rodney R.
AU - Graham, James M.
AU - Hwang, Jae Yeon
AU - Varley, Katherine E.
AU - Toydemir, Reha M.
AU - Deininger, Michael W.
AU - Raetz, Elizabeth A.
AU - O’Hare, Thomas
N1 - Funding Information: 1Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; 2Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Utah, Salt Lake City, UT; 3Knight Cancer Institute, Oregon Health & Science University, Portland, OR; 4Howard Hughes Medical Institute, Portland, OR; 5Helen Diller Family Cancer Research Center, Benioff Children’s Hospital, San Francisco, CA; 6Department of Pathology, University of Utah, Salt Lake City, UT; 7Department of Oncological Sciences, University of Utah, Salt Lake City, UT; 8Department of Pediatrics, Division of Medical Genetics, University of Utah, Salt Lake City, UT and 9Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT, USA *MSZ and OA contributed equally. ξEAR and TO contributed equally Acknowledgments: we acknowledge the Pediatric Cancer Program Biobank with support from the Primary Children's Hospital and Intermountain Healthcare Foundations and the Children's Oncology Group Cell Bank. We acknowledge Amber D. Bowler for technical assistance. Funding Information: Funding: research reported in this publication was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under Award Number R01CA178397. The authors acknowledge support of funds in conjunction with the NIH / NCI Cancer Center Support Grant P30CA042014 awarded to the Huntsman Cancer Institute. JWT was supported by The Leukemia & Lymphoma Society, the V Foundation for Cancer Research, the Gabrielle’s Angel Foundation for Cancer Research, and the NCI (5R00CA151457-04; 1R01CA183947-01). BJD is an investigator for the Howard Hughes Medical Institute and is also supported by the NCI (2R01CA065823-21A1). JWT receives research support from Aptose, Array, AstraZeneca, Constellation, Genentech, Gilead, Incyte, Janssen, Seattle Genetics, Syros, Takeda; Scientific Advisory Board for Leap Oncology. B.J.D.’s institution (OHSU) receives clinical trial funding from Novartis, Bristol-Myers Squibb, and ARIAD.
PY - 2018/1/31
Y1 - 2018/1/31
UR - http://www.scopus.com/inward/record.url?scp=85041493678&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85041493678&partnerID=8YFLogxK
U2 - 10.3324/haematol.2017.165282
DO - 10.3324/haematol.2017.165282
M3 - Comment/debate
C2 - 29284681
AN - SCOPUS:85041493678
VL - 103
SP - e87-e91
JO - Haematologica
JF - Haematologica
SN - 0390-6078
IS - 2
ER -